摘要
目的探究影响NO(一氧化氮)吸入治疗PPHN(新生儿持续肺动脉高压)患儿预后的危险因素及防治策略。方法对2014年8月-2018年10月入住安庆市立医院NICU(新生儿重症监护室)采用NO吸入治疗的42例PPHN患儿的临床资料进行系统回顾性分析。根据预后情况将患儿分为治疗成功组(27例)和失败组(15例)。收集患儿性别、出生体重、胎龄、分娩方式、羊水有无污染、出生时有无窒息、有无宫内窘迫、PS(肺泡表面活性物质)的应用、入院时血气分析结果(pH值、BE值、PaO2、PaCO2)、血糖、血钙浓度、母亲年龄、肺动脉压力值、有无并发症、NO吸入时间、机械通气时间、机械通气模式等,通过单因素和多因素危险因素分析找出影响患儿预后的危险因素。结果单因素分析显示,成功组和失败组在早产、围产期异常、出生体重、应用PS(肺泡表面活性物质)、机械通气时间、NO吸入时间、有无并发症这些因素中差异有统计学意义(均P<0.05);logistic回归分析提示早产、应用PS、NO吸入时间、并发症是影响NO吸入治疗PPHN患儿预后的危险因素。结论早产、NO吸入时间短及出现并发症是影响NO吸入治疗PPHN患儿预后的独立危险因素,应用PS可改善NO吸入治疗PPHN患儿的预后。
Objective To investigate the risk factors and preventative measures for inhaled nitric oxide in persistent pulmonary hypertension of newborn(PPHN). Methods A retrospective study was conducted at the neonatal department of the Anqing Municipal Hospital in 42 infants with persistent pulmonary hypertension treated by inhaled nitric oxide from August 2014 to October 2018. They were divided into two groups, namely 27 patients with good prognosis and 15 patients with poor prognosis according to the prognosis of patients. Analysis of factors including gender, birth weight, gestational age, delivery way, amniotic fluid pollution, history of suffocation, fetal distress, use of pulmonary surfactant and complications, immediate arterial blood for neonatal asphyxia(the pH value, the BE value, PaO2, PaCO2), blood sugar level, blood calcium, age of mother, pulmonary artery wedge pressure, time of mechanical ventilation, and time of inhaled nitric oxide, etc. The data were compared by univariate and multivariate logistic regression analysis. Results Univariate analysis showed that preterm delivery, fetal distress, weight, time of mechanical ventilation, time of inhaled nitric oxide, use of pulmonary surfactant and complications were the risk factors(P<0.05). Logistic regression analysis showed that preterm delivery, time of inhaled nitric oxide, complications and use of pulmonary surfactant were the main risk factors. Conclusion Patients with premature delivery, time of inhaled nitric oxide and complications with persistent pulmonary arterial hypertension were treated by inhaled NO had poor outcomes. The application of pulmonary surfactant can improve the outcome.
作者
丁丹
王士杰
潘家华
DING Dan;WANG Shi-jie;PAN Jia-hua(Department of Paediatrics, Anqing Municipal Hospital, Anqing, Anhui 246003, China)
出处
《中华全科医学》
2019年第7期1157-1160,共4页
Chinese Journal of General Practice
基金
安徽省公益性技术研究联动计划项目(15011d04016)
